SCHOTT Pharma
€24.55Change from previous close: +0.82%Absolute change: +€0.20
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €3.68B
- Enterprise value
- €3.92B
- P/E (trailing 12 months)
- 27.2
- Forward P/E
- 22.3
- Price/book
- 3.67
- Price/sales
- 3.62
- EV/EBITDA
- 15.7
- EV/revenue
- 3.86
Profitability and growth
- Gross margin
- 31.2%
- Operating margin
- 17.4%
- Net margin
- 13.4%
- ROE
- 14.7%
- ROA
- 6.5%
- Revenue growth (year over year)
- 10.0%
- Earnings growth (year over year)
- -13.3%
Financial health
- Total cash
- €24.88M
- Total debt
- €308.26M
- Debt/equity
- 0.31
- Current ratio
- 1.61
- Quick ratio
- 0.74
Dividends
- Annual dividend per share
- €0.18
- Dividend yield
- 0.7%
- Payout ratio
- 20.0%
- Ex-dividend date
- February 4, 2026
Analysts and estimates
- Average price target
- €23.68
- Median price target
- €25.00
- High price target
- €27.10
- Low price target
- €13.00
- Analysts with a price target
- 13
- Forward EPS
- €1.10
- EPS estimate, current year
- €0.99
Shares and trading
- Beta
- 0.99
- Average volume
- 73.78K
- Shares outstanding
- 150.61M
- Float
- 34.35M
- Institutional ownership
- 19.9%
- Insider ownership
- 77.0%